Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions

References

• Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–452. doi:10.1164/rccm.201111-2042ST22336677
   PubMed Web of Science ®Google Scholar
• Roche N. Activity limitation: a major consequence of dyspnoea in COPD. Eur Respir Rev. 2009;18:54–57. doi:10.1183/09059180.0000130920956125
   PubMedGoogle Scholar
• Mullerova H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9:e85540. doi:10.1371/journal.pone.008554024427316
   PubMed Web of Science ®Google Scholar
• Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression – important psychological comorbidities of COPD. J Thorac Dis. 2014;6:1615–1631. doi:10.3978/j.issn.2072-1439.2014.09.2825478202
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD. 2007;4:225–236. doi:10.1080/1541255070148045517729066
   PubMedGoogle Scholar
• Faisal A, Alghamdi BJ, Ciavaglia CE, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. 2016;193:299–309. doi:10.1164/rccm.201504-0841OC26407036
   PubMed Web of Science ®Google Scholar
• Guenette JA, Chin RC, Cheng S, et al. Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur Respir J. 2014;44:1177–1187. doi:10.1183/09031936.0003471425142487
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Ora J, Webb KA, Laveneziana P, Jensen D. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol. 2009;167:116–132. doi:10.1016/j.resp.2009.01.01019450767
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Guenette JA, Faisal A, et al. Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J. 2016;48:694–705. doi:10.1183/13993003.00077-201627492828
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Webb KA, Harle I, Neder JA. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future. Expert Rev Respir Med. 2016;10:823–834. doi:10.1080/17476348.2016.118286727115291
   PubMed Web of Science ®Google Scholar
• O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:180–184. doi:10.1513/pats.200508-093DO16565429
   PubMedGoogle Scholar
• O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Al E. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc. 2007;4:145–168. doi:10.1513/pats.200611-159CC17494725
   PubMedGoogle Scholar
• Raghavan N, Webb K, Amornputtisathaporn N, O'Donnell DE. Recent advances in pharmacotherapy for dyspnea in COPD. Curr Opin Pharmacol. 2011;11:204–210. doi:10.1016/j.coph.2011.03.00221450522
   PubMed Web of Science ®Google Scholar
• O'Donnell DE. Activity-related dyspnoea in chronic pulmonary diseases: new mechanistic insights. Tanaffos. 2017;16:S5–S6.29158746
   PubMedGoogle Scholar
• O'Donnell DE, Elbehairy AF, Berton DC, Domnik NJ, Neder JA. Advances in the evaluation of respiratory pathophysiology during exercise in chronic lung diseases. Front Physiol. 2017;8:82.28275353
   PubMed Web of Science ®Google Scholar
• Mahler DA, O'Donnell DE. Recent advances in dyspnea. Chest. 2015;147:232–241. doi:10.1378/chest.14-080025560861
   PubMed Web of Science ®Google Scholar
• Antoniu SA. Descriptors of dyspnea in obstructive lung diseases. Multidiscip Respir Med. 2010;5:216–219. doi:10.1186/2049-6958-5-3-21622958466
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Webb KA, Neder JA. Lung hyperinflation in COPD: applying physiology to clinical practice. COPD Res Pract. 2015;1:4. doi:10.1186/s40749-015-0008-8
   Google Scholar
• Guenette JA, Webb KA, O'Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J. 2012;40:322–329. doi:10.1183/09031936.0015771122183485
   PubMed Web of Science ®Google Scholar
• Stickland MK, Fuhr DP, Edgell H, et al. Chemosensitivity, cardiovascular risk, and the ventilatory response to exercise in COPD. PLoS One. 2016;11:e0158341. doi:10.1371/journal.pone.015834127355356
   PubMed Web of Science ®Google Scholar
• Ferguson GT. Why does the lung hyperinflate? Proc Am Thorac Soc. 2006;3:176–179. doi:10.1513/pats.200508-094DO16565428
   PubMedGoogle Scholar
• Nishimura K, Yasui M, Nishimura T, Oga T. Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD? Respir Res. 2011;12:135. doi:10.1186/1465-9921-12-12221988843
   PubMed Web of Science ®Google Scholar
• Gagnon P, Guenette JA, Langer D, et al. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:187–201. doi:10.2147/COPD.S3893424600216
   PubMed Web of Science ®Google Scholar
• Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:622–629. doi:10.1164/rccm.200707-1064OC18006885
   PubMed Web of Science ®Google Scholar
• Chin RC, Guenette JA, Cheng S, et al. Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2013;187:1315–1323. doi:10.1164/rccm.201211-1970OC23590271
   PubMed Web of Science ®Google Scholar
• GOLD. Global initiative for chronic obstructive lung disease. Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-POCKET-GUIDE-FINAL_WMS.pdf. Accessed 312 2019.
   Google Scholar
• Ozge C, Ozge A, Unal O. Cognitive and functional deterioration in patients with severe COPD. Behav Neurol. 2006;17:121–130.16873924
   PubMed Web of Science ®Google Scholar
• Dodd JW, Chung AW, van Den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–245. doi:10.1164/rccm.201202-0355OC22652026
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Lin J, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. AJNR Am J Neuroradiol. 2013;34:334–339. doi:10.3174/ajnr.A323522859277
   PubMed Web of Science ®Google Scholar
• Zhang J, Yan X, Shi J, Gong Q, Weng X, Liu Y. Structural modifications of the brain in acclimatization to high-altitude. PLoS One. 2010;5:e11449. doi:10.1371/journal.pone.001144920625426
   PubMed Web of Science ®Google Scholar
• Esser RW, Stoeckel MC, Kirsten A, et al. Structural brain changes in patients with COPD. Chest. 2016;149:426–434. doi:10.1378/chest.15-002726203911
   PubMed Web of Science ®Google Scholar
• Stoeckel MC, Esser RW, Gamer M, Buchel C, von Leupoldt A. Brain responses during the anticipation of dyspnea. Neural Plast. 2016;2016:6434987. doi:10.1155/2016/526067127648309
   PubMed Web of Science ®Google Scholar
• Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest. 2011;140:618–625. doi:10.1378/chest.10-325721493698
   PubMed Web of Science ®Google Scholar
• Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144:766–777. doi:10.1378/chest.12-191123429910
   PubMed Web of Science ®Google Scholar
• Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119:21–31. doi:10.1016/j.amjmed.2006.08.00416996896
   PubMed Web of Science ®Google Scholar
• Hayen A, Herigstad M, Pattinson KT. Understanding dyspnea as a complex individual experience. Maturitas. 2013;76:45–50. doi:10.1016/j.maturitas.2013.06.00523849705
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Gebke KB. Activity restriction in mild COPD: a challenging clinical problem. Int J Chron Obstruct Pulmon Dis. 2014;9:577–588. doi:10.2147/COPD.S6276624940054
   PubMed Web of Science ®Google Scholar
• Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104:1005–1011. doi:10.1016/j.rmed.2010.01.01220167463
   PubMed Web of Science ®Google Scholar
• Vozoris NT, O'Donnell DE. Smoking, activity level and exercise test outcomes in a young population sample without cardiopulmonary disease. J Sports Med Phys Fitness. 2015;55:787–796.25611081
   PubMed Web of Science ®Google Scholar
• Herigstad M, Hayen A, Evans E, et al. Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest. 2015;148:953–961. doi:10.1378/chest.15-041626134891
   PubMed Web of Science ®Google Scholar
• Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ. Measurement of breathlessness in advanced disease: a systematic review. Respir Med. 2007;101:399–410. doi:10.1016/j.rmed.2006.07.00316914301
   PubMed Web of Science ®Google Scholar
• Belfer MH, Reardon JZ. Improving exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease. J Am Osteopath Assoc. 2009;109:268–278.19451260
   PubMedGoogle Scholar
• Anzueto A, Miravitlles M. Pathophysiology of dyspnea in COPD. Postgrad Med. 2017;129:366–374. doi:10.1080/00325481.2017.130119028277858
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Elbehairy AF, Webb KA, Neder JA. The link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14:S30–S39. doi:10.1513/AnnalsATS.201610-834FR28398073
   PubMed Web of Science ®Google Scholar
• Jones P, Lareau S, Mahler DA. Measuring the effects of COPD on the patient. Respir Med. 2005;99 Suppl B:S11–S18. doi:10.1016/j.rmed.2005.09.011
   Web of Science ®Google Scholar
• Mahler DA, Ward J, Fierro-Carrion G, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD. 2004;1:165–172.17136984
   PubMedGoogle Scholar
• Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest. 2007;132:1283–1290. doi:10.1378/chest.07-070317646223
   PubMed Web of Science ®Google Scholar
• Keil DC, Stenzel NM, Kuhl K, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014;11:31–40. doi:10.1177/147997231351688124431409
   PubMed Web of Science ®Google Scholar
• Willgoss TG, Goldbart J, Fatoye F, Yohannes AM. The development and validation of the anxiety inventory for respiratory disease. Chest. 2013;144:1587–1596. doi:10.1378/chest.13-016823907347
   PubMed Web of Science ®Google Scholar
• Bateman ED, Ferguson GT, Barnes N, et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J. 2013;42:1484–1494. doi:10.1183/09031936.0020021223722616
   PubMed Web of Science ®Google Scholar
• Donohue JF, Maleki-Yazdi MR, Kilbride S, Mehta R, Kalberg C, Church A. Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. Respir Med. 2013;107:1538–1546. doi:10.1016/j.rmed.2013.06.00123830094
   PubMed Web of Science ®Google Scholar
• Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). Eur Respir J. 2015;45:969–979. doi:10.1183/09031936.0013601425573406
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Rabe KF, Ferguson GT, et al. Efficacy and safety of glycopyrrolate/formoterol metered dose inhaler formulated using Co-Suspension Delivery Technology in patients with COPD. Chest. 2017;151:340–357. doi:10.1016/j.chest.2016.11.02827916620
   PubMed Web of Science ®Google Scholar
• Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939–944.12403875
   PubMed Web of Science ®Google Scholar
• Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;15:CD006429.
   Google Scholar
• Nishino T. Dyspnoea: underlying mechanisms and treatment. Br J Anaesth. 2011;106:463–474. doi:10.1093/bja/aer04021378105
   PubMed Web of Science ®Google Scholar
• Donesky D, Nguyen HQ, Paul SM, Carrieri-Kohlman V. The affective dimension of dyspnea improves in a dyspnea self-management program with exercise training. J Pain Symptom Manage. 2014;47:757–771. doi:10.1016/j.jpainsymman.2013.05.01923954497
   PubMed Web of Science ®Google Scholar
• Wadell K, Webb KA, Preston ME, et al. Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. COPD. 2013;10:425–435. doi:10.3109/15412555.2012.75869623537344
   PubMedGoogle Scholar
• Langer D, Ciavaglia CE, Faisal A, et al. Inspiratory muscle training reduces diaphragm activation and dyspnea during exercise in COPD. J Appl Physiol (1985). 2018;125:381–392. doi:10.1152/japplphysiol.01078.201729543134
   PubMed Web of Science ®Google Scholar
• Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37:416–425. doi:10.1183/09031936.0003181021282809
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Junkes-Cunha M, Smith J, Vestbo J. Management of dyspnea and anxiety in chronic obstructive pulmonary disease: a critical review. J Am Med Dir Assoc. 2017;18(1096):e1091–e1096 e1017. doi:10.1016/j.jamda.2017.09.007
   Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140:331–342. doi:10.1378/chest.10-252121273294
   PubMed Web of Science ®Google Scholar
• Hayata A, Minakata Y, Matsunaga K, Nakanishi M, Yamamoto N. Differences in physical activity according to mMRC grade in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2203–2208. doi:10.2147/COPD.S10969427695306
   PubMed Web of Science ®Google Scholar
• Celli BR, Decramer M, Wedzicha JA, et al. An Official American Thoracic Society/European Respiratory Society Statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191:e4–e27. doi:10.1164/rccm.201501-0044ST25830527
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61:772–778. doi:10.1136/thx.2006.06014516738033
   PubMed Web of Science ®Google Scholar
• Troosters T, van der Molen T, Polkey M, et al. Improving physical activity in COPD: towards a new paradigm. Respir Res. 2013;14:115. doi:10.1186/1465-9921-14-1924229341
   PubMed Web of Science ®Google Scholar
• Troosters T, Maltais F, Leidy N, et al. Effect of bronchodilation and exercise training with behavior modification on exercise tolerance and downstream effects on symptoms and physical activity in COPD. Am J Respir Crit Care Med. 2018;198:1021–1032. doi:10.1164/rccm.201706-1288OC29664681
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;(2):CD003793.25705944
   PubMed Web of Science ®Google Scholar
• Herigstad M, Faull OK, Hayen A, et al. Treating breathlessness via the brain: changes in brain activity over a course of pulmonary rehabilitation. Eur Respir J. 2017;50:1701029.
   Google Scholar
• Cabral LF, D’Elia Tda C, Marins Dde S, Zin WA, Guimaraes FS. Pursed lip breathing improves exercise tolerance in COPD: a randomized crossover study. Eur J Phys Rehabil Med. 2015;51:79–88.24691248
   PubMed Web of Science ®Google Scholar
• Spathis A, Booth S, Moffat C, et al. The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease. NPJ Prim Care Respir Med. 2017;27:27. doi:10.1038/s41533-017-0024-z28432286
   PubMed Web of Science ®Google Scholar
• Brighton LJ, Miller S, Farquhar M, et al. Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis. Thorax. 2018;74:270–281. doi:10.1136/thoraxjnl-2018-21158930498004
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Dyspnea: mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321–340. doi:10.1164/ajrccm.159.1.ats8989872857
   PubMed Web of Science ®Google Scholar
• Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2006;119:12–20. doi:10.1016/j.amjmed.2006.08.00316996895
   PubMed Web of Science ®Google Scholar
• Jones I, Kirby A, Ormiston P, et al. The needs of patients dying of chronic obstructive pulmonary disease in the community. Fam Pract. 2004;21:310–313.15128695
   PubMed Web of Science ®Google Scholar
• Webb M, Moody LE, Mason LA. Dyspnea assessment and management in hospice patients with pulmonary disorders. Am J Hosp Palliat Care. 2000;17:259–264. doi:10.1177/10499091000170041211883802
   PubMedGoogle Scholar
• Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. Eur Respir J. 2009;33:227–229. doi:10.1183/09031936.0017680819181910
   PubMed Web of Science ®Google Scholar
• Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;(3):CD002990.24665053
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163:585–591.12622605
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns. 2004;52:271–277. doi:10.1016/S0738-3991(03)00102-214998597
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778.3321537
   PubMed Web of Science ®Google Scholar
• van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13. doi:10.1186/1477-7525-1-1312773199
   PubMedGoogle Scholar
• Karloh M, Fleig Mayer A, Maurici R, Pizzichini MM, Jones PW, Pizzichini E. The COPD Assessment Test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest. 2016;149:413–425. doi:10.1378/chest.15-175226513112
   PubMed Web of Science ®Google Scholar
• Williams MT, John D, Frith P. Comparison of the dyspnoea-12 and multidimensional dyspnoea profile in people with COPD. Eur Respir J. 2017;49:1600773.
   Web of Science ®Google Scholar
• Yorke J, Swigris J, Russell AM, et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011;139:159–164. doi:10.1378/chest.10-069320595454
   PubMed Web of Science ®Google Scholar
• Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257–266.13823475
   PubMed Web of Science ®Google Scholar
• Stenton C. The MRC breathlessness scale. Occup Med (Lond). 2008;58:226–227. doi:10.1093/occmed/kqm16218441368
   PubMed Web of Science ®Google Scholar
• Banzett RB, O'Donnell CR, Guilfoyle TE, et al. Multidimensional dyspnea profile: an instrument for clinical and laboratory research. Eur Respir J. 2015;45:1681–1691. doi:10.1183/09031936.0003891425792641
   PubMed Web of Science ®Google Scholar
• Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. University of California, San Diego. Chest. 1998;113:619–624.9515834
   PubMed Web of Science ®Google Scholar